Press release
Ursodeoxycholic Acid Market (2026-2033) | Liver Disease Treatment, Bile Acid Therapy, Hepatology Drugs & Pharma Growth
Ursodeoxycholic Acid Market Size 2026
Download Free Sample Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/ursodeoxycholic-acid-market?kb
United States: Recent Industry Developments
✅ Mar 2026: AbbVie Inc. expanded its hepatology portfolio by advancing UDCA-based therapies targeting rare cholestatic liver diseases.
✅ Feb 2026: Mirum Pharmaceuticals reported positive clinical progress for bile acid therapies, strengthening its position in liver disease treatment markets.
✅ Jan 2026: Pfizer Inc. increased focus on gastrointestinal and liver disease segments, supporting wider adoption of bile acid-based therapeutics.
✅ Dec 2025: Intercept Pharmaceuticals enhanced commercialization strategies for liver disease treatments, boosting awareness of bile acid therapies including UDCA.
List of Key Players 2026:
Glenmark Pharmaceuticals Inc., Biobrick Pharma, Casca Remedies Pvt. Ltd., Wellona Pharma, ADDII BIOTECH PRIVATE LIMITED., Curivo Healthcare, Zoic Life Sciences, Biofield Pharma Pvt Ltd, Jabs Biotech Pvt. Ltd, and Captee.
Growth Forecast Projected 2026:
The Global Ursodeoxycholic Acid Market is anticipated to rise at a considerable rate during the forecast period, between 2026 and 2033. In 2025, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Key Developments 2025-2026:
✅ February 2026: Pharmaceutical companies accelerated production of ursodeoxycholic acid formulations to meet rising global demand for the treatment of chronic liver diseases and gallstone dissolution.
✅ January 2026: Market players enhanced formulation technologies, including improved tablet and capsule delivery systems, to increase bioavailability and patient compliance.
✅ December 2025: Increased clinical focus on liver disorders such as Primary Biliary Cholangitis and Non-Alcoholic Fatty Liver Disease supported expanded therapeutic adoption of UDCA.
✅ November 2025: Strategic collaborations and supply chain expansions strengthened global distribution networks, ensuring consistent availability of UDCA-based drugs.
✅ October 2025: Manufacturers optimized production processes and API sourcing strategies to improve cost efficiency and maintain quality standards.
How Our Market Research Process Works:
The global Ursodeoxycholic Acid Market research report is developed using a comprehensive combination of primary and secondary data sources. The study evaluates a wide range of industry-influencing factors, including government regulations, evolving market dynamics, competitive intensity, and historical performance trends. It also analyzes technological advancements, emerging innovations, and developments across related industries. In addition, the report assesses market volatility, growth opportunities, potential barriers, and key challenges that could impact the future expansion of the Ursodeoxycholic Acid ecosystem.
Request Strategic Market Customization: https://datamintelligence.com/customize/ursodeoxycholic-acid-market?kb
Japan: Recent Industry Developments
✅ Mar 2026: Mitsubishi Tanabe Pharma Corporation expanded research into UDCA formulations for chronic liver disease management.
✅ Feb 2026: EA Pharma Co., Ltd. strengthened its gastrointestinal drug portfolio with increased focus on bile acid-based therapies.
✅ Jan 2026: Zeria Pharmaceutical Co., Ltd. advanced production capabilities for UDCA formulations to meet rising domestic demand.
✅ Dec 2025: Kyowa Kirin Co., Ltd. explored pipeline expansion in hepatology, supporting innovation in bile acid-derived treatments.
Major Focused Key Segmentations 2026:
By Type: Synthetic Ursodeoxycholic Acid (UDCA), Biological Ursodeoxycholic Acid (UDCA)
By Application: Gallstones, Primary Biliary Cholangitis (PBC), Primary Sclerosing Cholangitis (PSC), Non-Alcoholic Fatty Liver Disease (NAFLD), Other Liver and Biliary Diseases
By Form: Tablets, Capsules, Suspension
Regional Growth Analysis for Market:
⇥ North America: Leads the market with strong demand for liver disease treatments and advanced pharmaceutical adoption.
⇥ Japan: Significant growth driven by high prevalence of liver disorders and well-established use of ursodeoxycholic acid therapies.
⇥ Europe: Expanding market supported by favorable healthcare systems and increasing diagnosis of chronic liver conditions.
⇥ Asia-Pacific (including China, India, and Southeast Asia): Rapidly growing due to rising healthcare access, large patient pool, and increasing awareness of liver disease management.
⇥ Middle East & Africa: Emerging demand fueled by improving healthcare infrastructure and growing focus on gastrointestinal and liver treatments.
We Provide Benefits of the Report:
Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.
Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.
Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.
Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.
Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.
Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.
Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.
Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.
Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.
Unlock Full 360° Strategic Report: https://www.datamintelligence.com/buy-now-page?report=ursodeoxycholic-acid-market?kb
FAQ
Q1: What is the current size of the Ursodeoxycholic Acid Market?
A: The Ursodeoxycholic Acid Market was valued at US$ 581.17 million in 2023 and is forecasted to hit US$ 1120.55 million by 2031
Q2: How rapidly will the Market expanding?
A: The Ursodeoxycholic Acid market is projected to grow at a CAGR of 9.8% between 2024 and 2031.
Get Unlimited Market Reports & Strategic Insights: https://www.datamintelligence.com/reports-subscription?kb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ursodeoxycholic Acid Market (2026-2033) | Liver Disease Treatment, Bile Acid Therapy, Hepatology Drugs & Pharma Growth here
News-ID: 4445634 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
ESR1 Mutated Metastatic Breast Cancer Diagnostics Market to Reach USD 93.21 Mill …
The global ESR1 mutated metastatic breast cancer diagnostics market reached USD 66.3 million in 2025 and is expected to reach USD 93.21 million by 2033, growing at a CAGR of 4.4% during the forecast period from 2026 to 2033. The market is witnessing steady growth driven by the increasing prevalence of hormone receptor-positive breast cancer and rising awareness regarding genetic mutation testing for targeted treatment. Growing adoption of precision oncology…
Oncology Molecular Diagnostics Market to Reach USD 6.46 Billion by 2033 at 6.2% …
The global oncology molecular diagnostics market reached USD 4.03 billion in 2025 and is expected to reach USD 6.46 billion by 2033, growing at a CAGR of 6.2% during the forecast period from 2026 to 2033. The market is witnessing steady growth driven by the increasing prevalence of cancer, rising demand for early and accurate diagnosis, and growing adoption of precision medicine approaches. Advancements in genomic technologies and increasing awareness…
Solar Energy Market to Reach USD 416.13 Billion by 2033 at 10.6% CAGR; Asia Paci …
The global solar energy market reached USD 190.16 billion in 2025 and is expected to reach USD 416.13 billion by 2033, growing at a CAGR of 10.6% during the forecast period from 2026 to 2033. The market is witnessing strong growth driven by increasing demand for clean and renewable energy sources, rising concerns over carbon emissions, and supportive government policies promoting solar power adoption. Rapid urbanization, growing electricity demand, and…
Zero Trust Security Market Set for Explosive Growth to US$ 137.54 Billion by 203 …
DataM Intelligence has released a new research report titled "Zero Trust Security Market Size 2026". The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in…
More Releases for Mar
George Chung's Longstanding Leadership in Mar Vista Real Estate
Byline: Magnifyde PR
Image: https://www.globalnewslines.com/uploads/2026/04/06922deb1840587a4107af708a1f6ecf.jpg
In the Los Angeles neighborhood of Mar Vista, real estate expertise often comes down to familiarity with the community itself. Few professionals embody that local focus more clearly than George Chung, President Broker of George Chung Realtors. Over the course of his career, he has built a reputation centered on a single neighborhood, developing an unusually deep knowledge of the housing market in the 90066 area.
While many…
Consumer Adoption Of Smartphones And Tablets Fuels The Mobile Augmented Reality …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Mobile Augmented Reality (MAR) Market Size Growth Forecast: What to Expect by 2025?
In recent years, the market size of mobile augmented reality (MAR) has been expanding dramatically. The market is projected to increase from $27.57 billion in 2024 to $37.19 billion in 2025, with a compound annual growth…
1 New Article from Happy Smoking - MAR 2025
Happy Smoking is your definitive guide to smoking culture, providing expert reviews, comprehensive guides, and a platform for aficionados to connect and share their passion. We offer responsible, accurate information on enjoying cigars, pipes, and hookahs
.
Austin, TX - MAR 2025: Happy Smoking, a leader in smoking guides and expert reviews, is thrilled to announce the publishing of 1 new article on our platform. This month's update includes a diverse range…
Bungalows Del Mar Office by Harbor Associates in Del Mar, California Defies Nati …
Image: https://www.abnewswire.com/upload/2025/01/5bf83fc4238a3b3089be31e9b2ba64df.jpg
Seal Beach, CA - January 17, 2025 - Harbor Associates, LLC ("Harbor"), a value add and opportunistic buyer and owner in the office market, completed the lease up of the Bungalows Del Mar Office (https://www.thebungalowsdelmar.com/) despite the pandemic and work from home trends and now the recession that has slowed traditional office leasing. This Del Mar office space created by Harbor has been so successful that a rare…
Mobile Augmented Reality (MAR) Market 2021 | Detailed Report
The Mobile Augmented Reality (MAR) research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market’s key players. Furthermore, the report offers insightful market data and information about the…
Casa Del Mar - Bronx's Exquisite Bar and Restaurant
Bronx, New York City, Release: March 19, 2020
Seafood Dining at Its Best
Are you on a seafood diet?
If you are on a seafood diet, then what's better than sitting at Casa Del Mar, get hooked on seafood at a beautiful restaurant located in the heart of the Bronx that features the most exquisite seafood cuisine of all times.
Established on, the restaurant is an ideal seafood destination for all the gastronomes and…
